Ondansetron Hydrochloride vials recalled due to sterility assurance concerns
Olympia Compounding Pharmacy recalls 911 vials of Ondansetron Hydrochloride (1 mg/mL) due to lack of sterility assurance. The product was distributed nationwide in the USA, Puerto Rico, and US Virgin Islands.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a parenteral drug product with sterility assurance concerns. While no illnesses or injuries have been reported, the theoretical risk of infection from an injectable product with unassured sterility qualifies as a risk-of-harm product where injury has not yet been reported, meeting the High severity criterion.
Plain-English summary
Olympia Compounding Pharmacy is recalling 911 vials of Ondansetron Hydrochloride, 1 mg/mL, Multi-Dose 30 mL vials (NDC 73198-0127-30). The recalled lot is B24015-22 with a Beyond Use Date of 8/15/2022.
The product is being recalled because the manufacturer cannot assure that the vials maintain their sterility. This is a significant concern for multi-dose vials intended for injection, as lack of sterility can pose a risk of infection.
The recalled vials were distributed nationwide in the United States, Puerto Rico, and the U.S. Virgin Islands.
Patients and healthcare providers who have received this product should discontinue use immediately and consult with their healthcare provider about alternative treatments. Healthcare facilities should verify their inventory against the lot number and remove any affected product from circulation.
The recalled product
- Product
- Ondansetron Hydrochloride, 1 mg/mL, Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0127-30.
- Category
- Drug — Injectable
- Affected units
- 911
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: B24015-22 BUD: 8/15/2022
Distribution
Part of a larger recall action
This product is one of 53 recalled by Olympia Compounding Pharmacy dba Olympia Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 53 products in this recall →Related recalls
Same manufacturer · Olympia Compounding Pharmacy dba Olympia Pharmacy
See all →- HighFDA Recalls Compounded Papaverine Injection Due to Sterility Assurance
FDA (Drugs) · 2022-06-01
- HighFDA Recalls Amino Blend Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2022-06-01
- HighFDA Recalls Testosterone Cypionate Injection Vials for Lack of Sterility Assurance
FDA (Drugs) · 2022-06-01
- HighCompounded pharmaceutical vials recalled due to sterility assurance failure
FDA (Drugs) · 2022-06-01
- HighCompounded Injectable Formula F1 Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-06-01
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22